SILO vs XLV
Silo Pharma Inc (SILO) versus Health Care Select Sector SPDR® Fund (XLV) — a side-by-side from cached financials, not a winner call.
Silo Pharma Inc (SILO) is a biotechnology company listed on US.
Health Care Select Sector SPDR® Fund (XLV) common stock listed on US.
Latest reported SILO revenue for 2026-06-30 was $18.0K. Net income was -$2.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SILO currently screens at market cap $4.4M.
XLV does not have a complete income-statement cache yet.
SILO currently screens at market cap $4.4M. XLV currently screens at market cap $0.
Not investment advice. Open the SILO and XLV stock pages for the full models.
Not investment advice.